Keyphrases
Activated Macrophages
7%
Anti-tumor Necrosis Factor (anti-TNF)
7%
Apoptosis
23%
Clinical Trials
7%
Contractile Function
7%
Coronary Ligation
7%
Cross-border Region
7%
Cytokine Expression
7%
Diastolic Dysfunction
7%
Diastolic Function
7%
Factor Strategy
7%
Fibrosis
7%
Gene Expression
7%
H9c2 Cardiomyocytes
7%
Heart Failure
100%
Hypertrophy
23%
Inflammation
7%
Inflammatory Activity
100%
Interleukin
7%
Interleukin-10
7%
Interleukin-1β
7%
Interleukin-6
7%
Interleukin-6 Gene
7%
JNK2
15%
Kinase Activation
7%
Nuclear factor-B
100%
Nuclear factor-κB
23%
Opposing Effects
7%
Overexpression
7%
Oxidative Stress
15%
P38 Mitogen-activated Protein Kinase (p38 MAPK)
23%
Post-infarction
7%
Preclinical Data
7%
Pro-apoptotic
7%
Sham
7%
Stress Function
7%
TNF Receptor 1 (TNFR1)
100%
TNF Receptor 2 (TNFR2)
53%
Tumor Necrosis Factor Antagonist
7%
Tumor Necrosis Factor-α
30%
Immunology and Microbiology
Cardiac Muscle Cell
14%
Complement Factor B
100%
Cytokine
28%
Gene Expression
14%
Interleukin 1
14%
Interleukin 10
14%
Interleukin 6
28%
Macrophage
14%
Mitogen
42%
Neutralization
14%
Oxidative Stress
28%
Programmed Cell Death
42%
Tumor Necrosis Factor
85%
Tumor Necrosis Factor Receptor
100%
Tumor Necrosis Factor Receptor 2
100%
Upregulation
14%
Wild Type
57%
Medicine and Dentistry
Alternative Complement Pathway C3 C5 Convertase
100%
Cardiac Muscle Cell
7%
Clinical Trial
7%
Congestive Heart Failure
100%
Contractile Function
7%
Coronary Artery Ligation
7%
Cytokine
15%
Diastolic Dysfunction
7%
Diastolic Function
7%
Fibrosis
7%
Gene Expression
7%
Interleukin 1
7%
Interleukin 10
7%
Interleukin 6
15%
Macrophage
7%
Mitogen Activated Protein Kinase P38
23%
Neutralization
7%
Nuclear Factor
100%
Oxidative Stress
15%
Programmed Cell Death
23%
Receptor
7%
Tumor Necrosis Factor
46%
Tumor Necrosis Factor Receptor
100%
Tumor Necrosis Factor Receptor 2
53%
Upregulation
7%
Biochemistry, Genetics and Molecular Biology
Cardiac Muscle Cell
16%
Clinical Trial
16%
Complement Factor B
100%
Cytokine
33%
Gene Expression
16%
Interleukin 10
16%
Interleukin 6
33%
Interleukin-1
16%
Macrophage
16%
Oxidative Stress
33%
P38 Mitogen-Activated Protein Kinases
50%
Programmed Cell Death
50%
Tumor Necrosis Factor
100%
Tumor Necrosis Factor Receptor
100%
Upregulation
16%
Wild Type
66%
Pharmacology, Toxicology and Pharmaceutical Science
Alternative Complement Pathway C3 C5 Convertase
100%
Clinical Trial
7%
Congestive Heart Failure
100%
Cytokine
15%
Diastolic Dysfunction
7%
Fibrosis
7%
Inflammation
7%
Interleukin 1
7%
Interleukin 10
7%
Interleukin 6
15%
Mitogen Activated Protein Kinase P38
23%
Nuclear Factor
100%
Receptor
7%
Tumor Necrosis Factor
46%
Tumor Necrosis Factor Receptor
100%
Tumor Necrosis Factor Receptor 2
53%